alpha-V beta-1/alpha-V beta-6 Integrin inhibitor (DICE Therapeutics)

N/A

Report date: 2025/03/14 16:24:05
NME

Base Information

Drug Namealpha-V beta-1/alpha-V beta-6 Integrin inhibitor (DICE Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-V/beta-6 inhibitorsIntegrin alpha-V/beta-1 inhibitors
TargetsIntegrin alpha-V/beta-1Integrin alpha-V/beta-6
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDice Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDice Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A